UPDATE | January 30, 2023

Strength in Cell Line Development - How a streamlined CLD process can fast-track biologics to IND

  • MAIL

Strength in Cell Line Development - How a streamlined CLD process can fast-track biologics to IND

Optimization of cell culture conditions, introduction of screening technologies, and a well-developed proprietary line is crucial to enhance program efficiency and shorten commercial timelines without affecting the yield or quality of a product. In this article with the Medicine Maker, You-lim Kim, a lead scientist in our Cell Line Development Group, shares her insights on how a streamlined CLD process can fast-track biologics to IND.

Read more

Strength in Cell Line Development - How a streamlined CLD process can fast-track biologics to IND

Optimization of cell culture conditions, introduction of screening technologies, and a well-developed proprietary line is crucial to enhance program efficiency and shorten commercial timelines without affecting the yield or quality of a product. In this article with the Medicine Maker, You-lim Kim, a lead scientist in our Cell Line Development Group, shares her insights on how a streamlined CLD process can fast-track biologics to IND.

Read more 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required